Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Parents Are Drugging Kids For An Academic Edge!
According to a recent article in the New Yorker, college students are taking neurological drugs like Adderall and Ritalin to help them party hard -- while giving them an academic edge. What"s even worse is that this trend isn"t just occurring in colleges. Parents are giving their young kids Ritalin to help them gain a competitive advantage over their peers, even when they"re not suffering from ADD or ADHD.
generic viagra online
Abbott Initiates Trial Of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes From SPIRIT Family Of Trials
Abbott (NYSE: ABT) announced the initiation of SPIRIT PRIME, a clinical trial to study the performance of the company"s next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System, currently an investigational device, for the treatment of coronary artery disease. Results from SPIRIT PRIME will be used to support the regulatory filing for XIENCE PRIME in the United States. The first patient was enrolled into the SPIRIT PRIME clinical trial at Hillcrest Medical Center in Tulsa, Okla., by Rajesh Chandwaney, M.D.
News of the day
Ongoing Study Shows That Endovascular Therapy Is Associated With High Cure Rate For Childhood Eye Cancer
Expanded results of a study conducted on children with eye cancer (retinoblastoma) shows that chemotherapy delivered through endovascular (through the vessel) means not only successfully cures the cancer in a majority of cases, but achieves this cure with preserved vision. Study outcomes were presented this week at the Society of NeuroInterventional Surgery (SNIS) 6th Annual Meeting in Boca Raton, FL by lead author Pierre Gobin, Professor of Radiology in Neurosurgery and Neurology at the Weill Cornell Medical Center at New York Presbyterian Hospital in New York City.
Diagnostics

Glasgow Based BioOut Active In Flu Vaccine Testing

BioOut is a strategic partner for several of the world"s leading vaccine manufacturers. As such, BioOut is currently working with partners on projects to develop vaccines against Pandemic Influenza (Swine Flu and Avian Flu). BioOut is a forward-thinking contract testing organisation which has been inspected and approved to GMP standard by the UK MHRA. The company has wide experience of testing and releasing virus vaccine, including Pandemic and Seasonal flu, and provides the release testing of vaccine lots to meet the European Pharmacopeia release guidelines. BioOut has expertise in the handling of vaccine harvests and neutralisation of the virus lots for testing. In a relatively new innovation BioOut can offer an EP compliant alternative method to the lengthy and costly Mycoplasma test EP 2.6.1; PCR methodologies are used to detect mycoplasma, this can reduce the timelines for this test to 2 days rather than the 35 days this test would normally require and reduce costs by a factor of 4. Nexxus Scotland


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009